Funding › Robotics

Remedy Robotics raises $62M Series B

Remedy Robotics: Funding will support clinical trials, advancement toward FDA approval, and planned commercial deployment of the company's AI-enabled endovascular robotic platform and software suite SAN FRANCISCO, Nov.

Round
Series B
Amount
$62M
Announced
Lead investors
Not disclosed
Headquarters

Source (found by the agent, not yet verified)

More: Remedy Robotics funding history · rounds in November 2026 · rounds in unknown country